Hip Reconstruction Devices Market Size to Hit USD 17.29 Billion by 2035

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Hip Reconstruction Devices Market

5.1. COVID-19 Landscape: Hip Reconstruction Devices Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Hip Reconstruction Devices Market, By Device Type

8.1. Hip Reconstruction Devices Market Revenue and Volume Forecast, by Device Type

8.1.1. Hip Arthroplasty (Total Hip Replacement)

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Hip Resurfacing Devices

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Partial Hip Replacement Devices

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Hip Revision Surgery Devices

8.1.4.1. Market Revenue and Volume Forecast

8.1.5. Others (Impingement Devices, etc.)

8.1.5.1. Market Revenue and Volume Forecast

Chapter 9. Global Hip Reconstruction Devices Market, By Material

9.1. Hip Reconstruction Devices Market Revenue and Volume Forecast, by Material

9.1.1. Metal-on-Polyethylene (MoP)

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Metal-on-Metal (MoM)

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Ceramic-on-Polyethylene (CoP)

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Ceramic-on-Ceramic (CoC)

9.1.4.1. Market Revenue and Volume Forecast

9.1.5. Hybrid (Ceramic on Metal, etc.)

9.1.5.1. Market Revenue and Volume Forecast

Chapter 10. Global Hip Reconstruction Devices Market, By Surgery Type

10.1. Hip Reconstruction Devices Market Revenue and Volume Forecast, by Surgery Type

10.1.1. Primary Hip Replacement Surgery

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Hip Revision Surgery

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Minimally Invasive Hip Surgery

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Robotic-assisted Hip Surgery

10.1.4.1. Market Revenue and Volume Forecast

Chapter 11. Global Hip Reconstruction Devices Market, By End-Use

11.1. Hip Reconstruction Devices Market Revenue and Volume Forecast, by End-Use

11.1.1. Hospitals

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Ambulatory Surgical Centers (ASCs)

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Specialty Orthopedic Clinics

11.1.3.1. Market Revenue and Volume Forecast

Chapter 12. Global Hip Reconstruction Devices Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Device Type

12.1.2. Market Revenue and Volume Forecast, by Material

12.1.3. Market Revenue and Volume Forecast, by Surgery Type

12.1.4. Market Revenue and Volume Forecast, by End-Use

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Device Type

12.1.5.2. Market Revenue and Volume Forecast, by Material

12.1.5.3. Market Revenue and Volume Forecast, by Surgery Type

12.1.5.4. Market Revenue and Volume Forecast, by End-Use

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Device Type

12.1.6.2. Market Revenue and Volume Forecast, by Material

12.1.6.3. Market Revenue and Volume Forecast, by Surgery Type

12.1.6.4. Market Revenue and Volume Forecast, by End-Use

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Device Type

12.2.2. Market Revenue and Volume Forecast, by Material

12.2.3. Market Revenue and Volume Forecast, by Surgery Type

12.2.4. Market Revenue and Volume Forecast, by End-Use

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Device Type

12.2.5.2. Market Revenue and Volume Forecast, by Material

12.2.5.3. Market Revenue and Volume Forecast, by Surgery Type

12.2.5.4. Market Revenue and Volume Forecast, by End-Use

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Device Type

12.2.6.2. Market Revenue and Volume Forecast, by Material

12.2.6.3. Market Revenue and Volume Forecast, by Surgery Type

12.2.6.4. Market Revenue and Volume Forecast, by End-Use

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Device Type

12.2.7.2. Market Revenue and Volume Forecast, by Material

12.2.7.3. Market Revenue and Volume Forecast, by Surgery Type

12.2.7.4. Market Revenue and Volume Forecast, by End-Use

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Device Type

12.2.8.2. Market Revenue and Volume Forecast, by Material

12.2.8.3. Market Revenue and Volume Forecast, by Surgery Type

12.2.8.4. Market Revenue and Volume Forecast, by End-Use

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Device Type

12.3.2. Market Revenue and Volume Forecast, by Material

12.3.3. Market Revenue and Volume Forecast, by Surgery Type

12.3.4. Market Revenue and Volume Forecast, by End-Use

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Device Type

12.3.5.2. Market Revenue and Volume Forecast, by Material

12.3.5.3. Market Revenue and Volume Forecast, by Surgery Type

12.3.5.4. Market Revenue and Volume Forecast, by End-Use

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Device Type

12.3.6.2. Market Revenue and Volume Forecast, by Material

12.3.6.3. Market Revenue and Volume Forecast, by Surgery Type

12.3.6.4. Market Revenue and Volume Forecast, by End-Use

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Device Type

12.3.7.2. Market Revenue and Volume Forecast, by Material

12.3.7.3. Market Revenue and Volume Forecast, by Surgery Type

12.3.7.4. Market Revenue and Volume Forecast, by End-Use

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Device Type

12.3.8.2. Market Revenue and Volume Forecast, by Material

12.3.8.3. Market Revenue and Volume Forecast, by Surgery Type

12.3.8.4. Market Revenue and Volume Forecast, by End-Use

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Device Type

12.4.2. Market Revenue and Volume Forecast, by Material

12.4.3. Market Revenue and Volume Forecast, by Surgery Type

12.4.4. Market Revenue and Volume Forecast, by End-Use

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Device Type

12.4.5.2. Market Revenue and Volume Forecast, by Material

12.4.5.3. Market Revenue and Volume Forecast, by Surgery Type

12.4.5.4. Market Revenue and Volume Forecast, by End-Use

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Device Type

12.4.6.2. Market Revenue and Volume Forecast, by Material

12.4.6.3. Market Revenue and Volume Forecast, by Surgery Type

12.4.6.4. Market Revenue and Volume Forecast, by End-Use

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Device Type

12.4.7.2. Market Revenue and Volume Forecast, by Material

12.4.7.3. Market Revenue and Volume Forecast, by Surgery Type

12.4.7.4. Market Revenue and Volume Forecast, by End-Use

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Device Type

12.4.8.2. Market Revenue and Volume Forecast, by Material

12.4.8.3. Market Revenue and Volume Forecast, by Surgery Type

12.4.8.4. Market Revenue and Volume Forecast, by End-Use

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Device Type

12.5.2. Market Revenue and Volume Forecast, by Material

12.5.3. Market Revenue and Volume Forecast, by Surgery Type

12.5.4. Market Revenue and Volume Forecast, by End-Use

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Device Type

12.5.5.2. Market Revenue and Volume Forecast, by Material

12.5.5.3. Market Revenue and Volume Forecast, by Surgery Type

12.5.5.4. Market Revenue and Volume Forecast, by End-Use

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Device Type

12.5.6.2. Market Revenue and Volume Forecast, by Material

12.5.6.3. Market Revenue and Volume Forecast, by Surgery Type

12.5.6.4. Market Revenue and Volume Forecast, by End-Use

Chapter 13. Company Profiles

13.1. Zimmer Biomet Holdings, Inc.

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial PerDevice Typeance

13.1.4. Recent Initiatives

13.2. Stryker Corporation

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial PerDevice Typeance

13.2.4. Recent Initiatives

13.3. DePuy Synthes (Johnson & Johnson)

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial PerDevice Typeance

13.3.4. Recent Initiatives

13.4. Smith & Nephew plc

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial PerDevice Typeance

13.4.4. Recent Initiatives

13.5. Wright Medical Group N.V. (Acquired by Stryker)

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial PerDevice Typeance

13.5.4. Recent Initiatives

13.6. MicroPort Scientific Corporation

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial PerDevice Typeance

13.6.4. Recent Initiatives

13.7. B. Braun Melsungen AG

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial PerDevice Typeance

13.7.4. Recent Initiatives

13.8. Exactech, Inc.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial PerDevice Typeance

13.8.4. Recent Initiatives

13.9. DJO Global (part of Colfax Corporation)

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial PerDevice Typeance

13.9.4. Recent Initiatives

13.10. Arthrex, Inc.

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial PerDevice Typeance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

Answer : The hip reconstruction devices market size is expected to increase from USD 9.30 billion in 2025 to USD 17.29 billion by 2035.

Answer : The hip reconstruction devices market is expected to grow at a compound annual growth rate (CAGR) of around 6.40% from 2026 to 2035.

Answer : The major players in the hip reconstruction devices market include Zimmer Biomet Holdings, Inc., Stryker Corporation, DePuy Synthes (Johnson & Johnson), Smith & Nephew plc, Wright Medical Group N.V. (Acquired by Stryker), MicroPort Scientific Corporation, B. Braun Melsungen AG, Exactech, Inc., DJO Global (part of Colfax Corporation), Arthrex, Inc., Medtronic plc, Corin Group, Omni Life Science, Inc., Hapatec GmbH, and Cerapedics, Inc.

Answer : The driving factors of the hip reconstruction devices market are the rising prevalence of osteoarthritis and an aging population, which are increasing the demand for joint replacement procedures worldwide.

Answer : North America region will lead the global hip reconstruction devices market during the forecast period 2026 to 2035.